ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Symproic® Once-Daily Tablets C-II for the Treatment of Opioid-Induced Constipation in Adults with Ch
March 28, 2017The U.S. Food and Drug Administration (FDA) approved Symproic® (naldemedine) 0.2 mg tablets C-II as a once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult pat
Pharma Sources Insight January 2025
